FORMULATION FORUM: How Poorly Water Soluble APIs Present 505(b)(2) Opportunity

May 4, 2020, 12:00:00 AM

Ascendia Joins the Fight Against COVID-19

Apr 29, 2020, 12:00:00 AM

How to Select a CDMO to Improve Drug Bioavailability and Solubility

Apr 20, 2020, 12:00:00 AM

State of CDMO Market: Insight from Ascendia

Apr 14, 2020, 12:00:00 AM

Outsourcing Analytical Testing Special Report Features Ascendia

Apr 7, 2020, 12:00:00 AM

Benefits of Lipid-based Delivery Systems in Poorly Soluble Drugs

Apr 1, 2020, 12:00:00 AM

FORMULATION FORUM: Design & Development of LAI Dosage Forms

Mar 27, 2020, 12:00:00 AM

Contract Pharma Features Ascendia in Video Profile

Mar 24, 2020, 12:00:00 AM

Ascendia Featured in Improving Bioavailability & Solubility Article

Mar 24, 2020, 12:00:00 AM

How to Develop an Effective Formulation Strategy for Early Stage Drug Candidates

Jun 24, 2019, 12:00:00 AM

Ways in Which Nanotechnology Aids 505(b)(2) Product Development

May 28, 2019, 12:00:00 AM

How to Select a CDMO Partner for Early Stage Drug Development

Mar 27, 2019, 12:00:00 AM